SEP 08, 2020 10:30 AM PDT

Common Steroid Drug Reduces COVID-19 Deaths by 20%

WRITTEN BY: Annie Lennon

Hydrocortisone, a common and widely-available anti-inflammatory steroid drug, has been found to reduce the mortality rate in patients in intensive care by 20%. 

For the discovery, researchers conducted a meta-analysis of seven trials involving 1703 critically ill patients from 12 countries to investigate the effectiveness of three different types of common steroid treatments in treating COVID-19. Including hydrocortisone and methylprednisolone, they also analyzed the usage of dexamethasone, already approved for usage against COVID-19, to reduce mortality rates. 

When compared to those on a placebo, those treated with dexamethasone and hydrocortisone were around a third less likely to die during COVID-19 treatment. The mortality rate for those receiving methylprednisolone saw a smaller reduction. Although dexamethasone was shown to be marginally more effective than hydrocortisone, the researchers say that having other treatment options available could help alleviate future supply chain issues, and ultimately allow clinicians to administer whichever drug they feel most comfortable with. 

"The overall results support and are consistent with the findings from RECOVERY (a trial conducted by Oxford University investigating dexamethasone as a treatment for severely-ill COVID-19 patients) that corticosteroids reduce mortality in the sickest patients with COVID-19," says Jonathan Sterne, professor of medical statistics and epidemiology at the University of Bristol. 

"What we add is that these are a diverse group of patients from a variety of countries, and we have a consistent message from all these trials. The effect of hydrocortisone is also consistent with the effect of dexamethasone."

Although promising results that have already gone on to inform treatment practice in the UK (hydrocortisone will now be used by the UK's National Healthcare System (NHS) to fight COVID-19), the researchers say that the research comes with limitations. Firstly, they say that some of the investigators present in the trails did not take part in the meta-analysis. Furthermore, only one trial assessed methylprednisolone with a very small sample size. Thus, results for this steroid may not be conclusive. 

The researchers also say that although these treatments may be available over the counter, they should not be used as home remedies for COVID-19, nor as a preventative strategy. This comes as patients in the trials received the drugs via an intravenous drip, and not in the commonly available pill form. 

 

Sources: The BMJScience Alert

About the Author
  • Science writer with a keen interest in behavioral biology, consciousness medicine and technology. Her current focus is how the interplay of these fields can create meaningful interactions, products and environments.
You May Also Like
FEB 07, 2021
Drug Discovery & Development
Beta-Blockers Can Repair Broken Blood Vessels
FEB 07, 2021
Beta-Blockers Can Repair Broken Blood Vessels
Propranolol is a drug that can treat infantile haemangiomas but was found to also treat a blood vessel condition that le ...
MAR 03, 2021
Drug Discovery & Development
Keeping HIV Latent
MAR 03, 2021
Keeping HIV Latent
When (HIV) human immunodeficiency virus infects cells, it can go to sleep as opposed to make viral copies of itself&mdas ...
APR 14, 2021
Cancer
Cell Viability- Where to Begin?
APR 14, 2021
Cell Viability- Where to Begin?
Written By: Author As I pondered the title of this article, my thoughts immediately went back to a request by my Ph.D. a ...
APR 04, 2021
Drug Discovery & Development
Ion-Pump for Chemotherapy
APR 04, 2021
Ion-Pump for Chemotherapy
Patients of malignant brain tumors experience recurrences even after subsequent treatments. To address this issue, scien ...
APR 14, 2021
Drug Discovery & Development
Anti-Aging Compound Improves Glucose Uptake
APR 14, 2021
Anti-Aging Compound Improves Glucose Uptake
According to new research at Washington University School of Medicine in St. Louis, a substance shown to counteract aspe ...
MAY 06, 2021
Cannabis Sciences
New CBD Analog Outperforms Regular CBD for Pain Relief
MAY 06, 2021
New CBD Analog Outperforms Regular CBD for Pain Relief
Researchers from Temple University Health System have found that a novel cannabidiol (CBD) analog can reverse pain sensi ...
Loading Comments...